Human Albumin Market Report 2026

Human Albumin Market Overview

• The Human Albumin market growth in the historic period has been driven by increasing surgical procedures, widespread use in plasma volume replacement • Market expansion is supported by expansion of critical care infrastructure, rising liver disease prevalence • Growth Driver: Rising Chronic Disorders Fueling Growth In The Market • Market Trend: Regulatory Approvals Driving Competitive Advantage In The Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Human Albumin Market?

Human albumin is a naturally occurring protein found in plasma, responsible for maintaining oncotic pressure and facilitating the transport of hormones, enzymes, drugs, and other substances in the blood. Therapeutically, human albumin is administered as an intravenous solution derived from pooled human plasma to treat conditions such as hypovolemia, hypoalbuminemia, burns, and acute respiratory distress syndrome (ARDS). It is also used in surgeries, including liver transplants and dialysis, to restore blood volume and stabilize circulation. Its ability to bind and carry molecules makes it a critical component in medical treatments for fluid replacement and shock management. The main types of human albumin products include human serum albumin, recombinant albumin, and bovine serum albumin. Human serum albumin is a protein found in human blood plasma that plays a key role in maintaining osmotic pressure and transporting molecules like hormones and drugs. Human albumin is utilized in the production of human serum albumin products to ensure compatibility and maintain physiological functions in therapeutic applications. It is used for hypovolemia, hypoalbuminemia, burns and shock, liver diseases, neonatal conditions, surgical and critical care, and others, and is applied for therapeutics, drug formulation and vaccines, components of media, and others. It is used by various end users, such as hospitals and clinics, the pharmaceutical and biotechnology industries, and research institutes.

What Is The Human Albumin Market Growth Forecast?

The growth in the forecast period can be attributed to expansion of critical care infrastructure, rising liver disease prevalence, growing demand for recombinant albumin, increased pharmaceutical formulation usage, improving plasma collection systems. Major trends in the forecast period include rising demand in critical care settings, expansion of albumin use in liver disorders, growing adoption in dialysis and surgery, shift toward recombinant albumin products, increasing role in drug formulation.

Global Human Albumin Market Segmentation

1) By Product: Human Serum Albumin, Recombinant Albumin, Bovine Serum Albumin 2) By Clinical Indication: Hypovolemia, Hypoalbuminemia, Burns And Shock, Liver Diseases, Neonatal Conditions, Surgical And Critical Care, Other Clinical Indications 3) By Application: Therapeutics, Drug Formulation And Vaccine, Component Of Media, Other Applications 4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Industry, Research Institutes

What Is The Driver Of The Human Albumin Market?

The rising incidence of chronic disorders is expected to drive the human albumin market. Chronic disorders, also known as chronic diseases, are long-term conditions that persist over time and often require ongoing medical management. The rise in chronic disorders is primarily driven by factors such as aging populations, sedentary lifestyles, poor dietary choices, and increasing stress levels. Human albumin is used in chronic kidney disease to manage hypoalbuminemia and maintain oncotic pressure, improving fluid balance and reducing complications. For instance, in June 2023, according to the report published by Kidney Research UK, a UK-based charity, in the UK, approximately 7.2 million people, over 10% of the population, are affected by chronic kidney disease. Among them, 3.25 million individuals are in the severe stages, while an additional 3.9 million are in the early stages, frequently undiagnosed and symptom-free. By 2033, it is anticipated that the population with chronic kidney disease will reach 7.61 million. Therefore, the rising incidence of chronic disorders will drive the human albumin industry.

Key Players In The Global Human Albumin Market

Major companies operating in the human albumin market are Takeda Biopharmaceuticals Private Ltd., Merck KGaA, Baxter International Inc., CSL Behring, Grifols SA, Octapharma AG, Sanquin Plasma Products BV, Taibang Biologic Group, Bovogen Biologicals Pty Ltd., Akron Biotech

Global Human Albumin Market Trends and Insights

The key trend in the human albumin market is focusing on obtaining drug approval from authorities to gain a competitive edge in the industry. Securing drug approval ensures that a medication is safe, effective, and of high quality, which builds confidence among healthcare providers and patients. Additionally, it allows the product to be marketed and sold legally, thereby expanding its reach and potential for widespread use. For instance, in June 2023, Kedrion Biopharma Inc., an Italy-based biotechnology pharmaceutical company, announced the approval of Bio Products Laboratory (BPL)'s human albumin product by China's National Institutes for Food and Drug Control (NIFDC), marking a significant milestone as it is the first BPL product approved for the Chinese market. This approval enables regular shipments to China, the largest market for human albumin.

What Are Latest Mergers And Acquisitions In The Human Albumin Market?

In June 2024, Dyadic International, Inc., a US-based biotechnology company partnership with Proliant Health and Biologicals. With this partnership, Dyadic aims to commercialize animal-free recombinant human serum albumin products, leveraging its protein production technology alongside PHB’s established market position to target the growing $6 billion serum albumin market. Proliant Health and Biologicals is a US-based life sciences company.

Regional Insights

North America was the largest region in the human albumin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Human Albumin Market?

The human albumin market consists of sales of albumin solutions, albumin for plasma exchange, albumin for cell culture, and albumin for surgical applications. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Human Albumin Market Report 2026?

The human albumin market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the human albumin industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.